4697

Five companies that accounted for nearly 95 percent of the market in hip and knee surgical implants avoided criminal prosecution over financial inducements paid to surgeons to use their products by paying settlements and agreeing to new corporate compliance procedures and federal monitoring under 18-month agreements with the Department of Justice.